Beyond the White Box: Why Patient Friendly IP Packaging Matters
|
|
- Pearl Maria Ward
- 8 years ago
- Views:
Transcription
1 Beyond the White Box: Why Patient Friendly IP Packaging Matters KRISTEN DEVITO Global Director, CSS Business Solutions Catalent Pharma Solutions Presented to 17 March 2015
2 Introduction The increasing complexity and global nature of clinical trial designs have been in part enabled by the developments of IRT (Interactive Response Technology) systems to manage the supply chain In response to the increasing complexity, the industry has applied lean practices to clinical supply to improve speed and efficiency and reduce overall cost Standardization of clinical supplies has resulted in a one-sizefits-all approach to the design of the medication kit and clinical label The result is often unfriendly medication kits delivered to the end-user, our patient volunteers 2
3 Voice of the Patient - IMP Kits Factors which heavily influence the medication kit and label design include Dosage Form and Delivery Method Clinical Protocol Regulatory Requirements Efficiency / Cost Time constraints There is often a disconnect between the groups which determine the kit design and the groups which interact most often with the patient volunteers Stakeholders within the Clinical Supply Chain recognize that the actual medication kit has impact upon both the patient experience and patient and site compliance, also potentially influencing patient retention 3 3
4 Patient Kits: Past, Present, Future Patient kits of Past Patient Specific Kits Site based Randomization Schemes Coloured labels to aid clinical site and patient compliance Titration/variable dose schemes required patient kits collated to all possible dose progressions Typically one or two languages, single or multi-panel labels Visit Specific Dispensing Cartons Design emphasis 4 Dispensing and Dosing compliance Country specific Patient No Dose Level A Visit 5 Patient No Dose Level A Visit 4 Patient No Dose Level A Visit 3 Patient No Dose Level A Visit 2 Patient No Dose Level A Visit 1 Patient No Dose Level B Visit 5 Patient No Dose Level B Visit 4 Patient No Dose Level B Visit 3 Patient No Dose Level B Visit 2 Patient No Dose Level C Visit 5 Patient No Dose Level C Visit 4 Patient No Dose Level C Visit Patient Packs x 12 Visit Cartons =3600 Visit Cartons 4
5 Patient kits Today Standardised White cartons and labels Standard bottles, vial etc. Booklet labels Individual country pages with generic, coded cover panel Kit = a dispensable unit Multiple Kits may be dispensed at a single visit All look the same Design emphasis 5 Patient Kits: Past, Present, Future Regulations (getting all information on a label/booklet even if unreadable!) Cost effective packaging Flexibility of Supplies For same 5 dispensing visits 300 Patients x 5 Dispensing Kits =1500 Kits 5
6 Patient Feedback Survey on Clinical Trial Medicine Kits In response to industry desire to improve the patient volunteer experience, the International Society of Pharmaceutical Engineering (ISPE) in collaboration with the Center for Information and Study on Clinical Research Participation (CISCRP) and financial support of 11 industry sponsor and vendor companies, developed an online survey to solicit feedback directly from study volunteers on their experience with clinical medicine kits Distributed globally in 3 languages (English, French and Spanish) from May through September % respondents from United States 1,425 responding study volunteers with recent experience in a Ph II or Ph III clinical trial and took medication home Good mix of age, gender and representation from various therapeutic studies Reference: C. Milligan, J Schults and K. Getz. Assessing Pa4ent Experience with Clinical Trial Medicine Kits. Pharmaceu)cal Engineering, Volume 23, Issue 8 6 6
7 Patient Survey Results Overall Satisfaction and compliance with Medicine Kits Majority of respondents stated kits were easy to use and easy to store Patient perception of compliance-enabling impact by kit type 60% responded that design/layout of the kit helped them to take their medicine on schedule 30% responded kit design did not have impact and 11% did not remember Though blister packs more difficult to open for some volunteers, they indicated greater impact of aid in adherence to schedule Volunteers suggest adding dates/times to blister packaging would help track dose intake and promote adherence to study protocol Reference: C. Milligan, J Schults and K. Getz. Assessing Pa4ent Experience with Clinical Trial Medicine Kits. Pharmaceu)cal Engineering, Volume 23, Issue 8 7 7
8 Role of Kit Design in Compliance Most Important medication kit factors 82% of respondents self reported they always take clinical trial medicine on schedule Over 50% felt at least one type of reminder very useful with youngest age group responding favorably to daily reminders Perceived Usefulness of adherence reminders Reference: C. Milligan, J Schults and K. Getz. Assessing Pa4ent Experience with Clinical Trial Medicine Kits. Pharmaceu)cal Engineering, Volume 23, Issue 8 8 8
9 Feedback on Clinical Labels Booklet Labels 12% never opened or reach booklet label 14% opened and read booklet label on only some containers Pictorial Instructions Agreement that pictograms are helpful However, must be easy to interpret and communicate correct message Further research globally on clarity of message on patient behavior could support expanded use Reference: C. Milligan, J Schults and K. Getz. Assessing Pa4ent Experience with Clinical Trial Medicine Kits. Pharmaceu)cal Engineering, Volume 23, Issue 8 9 9
10 Expanding Role of Technologies in Compliance Study volunteers asked their perception of usefulness of receiving label information via various technologies Overall, respondents favorable to alternative methods to receive labeling information Younger respondents more open to using smartphone technologies and digital communication Similar responses when asked about receiving reminders via same technologies Reference: C. Milligan, J Schults and K. Getz. Assessing Patient Experience with Clinical Trial Medicine Kits. Pharmaceutical Engineering, Volume 23, Issue
11 Medication Kits Delivered to Patients Homes Interest in having repeat dispensing kits delivered to patients home 78% indicated it would be very helpful or somewhat helpful to have refills of study medications delivered directly to their home Respondents had also indicated within survey that ability to connect with site study personnel is important to satisfaction and compliance Maintaining connectivity to site while employing remote study execution will be important to success Reference: C. Milligan, J Schults and K. Getz. Assessing Patient Experience with Clinical Trial Medicine Kits. Pharmaceutical Engineering, Volume 23, Issue
12 Key Takeaways from Survey Results Study volunteers have a genuine intent to comply with the study and want the study to succeed Though generally satisfied with their medicine kits, with blister card designs a preference for aiding compliance, there are opportunities to improve upon their design and the delivery of information which would affect positively patient experience and compliance Study volunteers would like to have options to customize their experience There are quick wins we can employ now to improve New models are currently developing which improve the patient experience Future technologies supported by regulatory framework to further customize delivery of IMP to the patient 12 12
13 Improvements to Readability of Labels Label example- how do get label text from sponsors? Protocol No.: Catalent tab 4 mg or Matching Placebo Content: 20 Tablets Lot Number: Exp Date: Patient Number: XXXXXXXXXX XXXXXXXXXX EudraCT No.: Directions: For Oral Use Only. Take one tablet three times daily Investigational Drug. To be used by qualified investigators only. Store in original packaging to protect contents from light. Do not store over 25 Keep out of reach of children. Sponsor: Catalent Pharmaceuticals, Unit 107, Tenth Avenue, Deeside; Tel: XXXX Investigator Name: Site ID: Patient ID: 13 13
14 Improvements to Readability of Labels Key site/patient information larger and bolder Peel off label for site to fix to other face of box to assist site storage Text not all left justified, different font sizes and bolding used 14 14
15 Patient kits Tomorrow The supply of clinical materials is becoming a two-way street, with information flowing upstream from the patients and sites to drive the downstream flow of user focused products and services Patient friendly to aid compliance Use of colour / Smaller / Simplified kits Easy to transport (inc. cold chain solutions) Use of pictograms On-demand models will enable patient kit to be customised to level of country, site and ultimately patient preference Single language labels High visibility of the Kit ID number customised for Clinical Site convenience Link to other formats for accessing label information e-labels / videos Direct to Patient (DTP) shipments Design emphasis 15 Patient Kits The Future Include Patient & Clinical Site input Tailored to Therapeutic solution 15
16 Catalent Direct to Patient Value Proposition PATIENTS CLINICAL SITE TRIAL - Prevents missed treatments/doses - Supports pa4ents with long/difficult travel to site - Assists those with disabili4es or other health issues that can impact travel - Can eliminate needs and burden of transpor4ng returns - Supports pa4ent lifestyle e.g. vaca4on - Reduced travel costs - Simplified processes - Reduced storage burden - Travel fees eliminated - Could be possible to increase visit windows - Increased Pa4ent reten4on/reduced drop out - Improved pa4ent compliance - Final mile control of product stability - Op4mized drug accountability and returns - Reduced waste Pa4ent feels valued and more likely to comply and complete trial 16 16
17 Will be key Apps for patients Technology - PUSH information - Expiry updates - Label updates - Visit reminders - Delivery reminders - Dosing reminders - PULL information - Compliance information - Diary information - Confirmation of receipts for home delivery 17 17
18 E-labeling Concept E-labeling: the labeling of secondary medicine packs/kits with non-country specific labels but with serialized barcode or RFID chip which will enable delivery of information to the site and to the patient Delivery of custom information delivered for each pack Local language translation of clinical label Real-time expiry information Instructions videos specific to dispensed pack Dosing reminders Cumulative temperature excursion data Not currently within regulatory framework Reference: K. Gram, H. Heessakers, R. Lauwers and S. Sonnenberg. Patient Centric Innovations in the Clinical Supply Chain. Pharmaceutical Engineering, Volume 34, Issue
19 Summary The patient volunteer experience and perceptions of an improved supply chain for clinical trials must be taken into account in order to recruit and retain this essential resource Patient-centric considerations and improvements in medicine kit design and the overall supply chain can be implemented now within current technology and regulatory constraints Leveraging available technologies and best practices within the clinical supply chain do not need to increase costs in order to achieve patient focus, but may re-distribute the cost Younger populations as current and future study volunteers will set new expectations on the definition of a positive study volunteer experience in regard to their study medications Increase opportunities for change by training on concepts learned from patient and site feedback up through the supply chain 19 19
e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015
e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 PHARMAPACK 2015 1 Mobile health x2 30 months 100 000 mapps Source: research2guidance, mhealth App Market Report 2013-2017
More informationBest Practice Approaches to Improving Clinical Supply Chain Management. Matthew Do Client Development Lead Almac Pharmaceutical Services
Best Practice Approaches to Improving Clinical Supply Chain Management Matthew Do Client Development Lead Almac Pharmaceutical Services A variety of challenges complicate trial supply management Multiple
More informationOptimizing the Clinical Trial Supply Chain
white paper Optimizing the Clinical Trial Supply Chain Ensuring the right items arrive in the right place, in the right quantity, at the right time and within budget. Testing out new medicines around the
More informationAGILE RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS: A RECIPE FOR SPEED, SIMPLICITY AND SERVICE
WHITE PAPER AGILE RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS: A RECIPE FOR SPEED, SIMPLICITY AND SERVICE Randomization is fundamental to clinical trials it enables treatment group balance, eliminates
More informationIntroduction. VP, Sales in a Global Courier Company
ARTICLE AUGUST 2014 Abstract: Impact analysis of Just in Time packaging and labeling on clinical supply chain Clinical supply chain is in intense pressure for better management due to factors like globalization
More informationDocument Title: Supply of Clinical Trials Investigational Material: Dispensing, Returns and Accountability
Document Title: Supply of Clinical Trials Investigational Material: Document Number: SOP072 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G
More informationClinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management
Brochure More information from http://www.researchandmarkets.com/reports/2226324/ Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management Description:
More informationMinimize overspend by gaining visibility of total demand
Minimize overspend by gaining visibility of total demand Patti Seymour 9th Annual Clinical Trials Supplies and Packaging October 10-12, 2011 BioProcess Technology Consultants www.bptc.com Supply and Demand
More informationPatient Inclusion in the Clinical Trial Process at Novartis Working to Make it Reality
Patient Inclusion in the Clinical Trial Process at Novartis Working to Make it Reality Therese Johnsen, Clinical Trial Intelligence Manager 8 June 2015, London Transparent, Patient Focused Drug Development
More informationUnderstanding When to Employ IVR and IWR independently or in Combination
Understanding When to Employ IVR and IWR independently or in Combination Scott C. Wong Sr. Systems Analyst, IVRS Central Management Global Investigational Materials Supply Chain Celgene Agenda What are
More informationLorna Briddick Managing Partner Brizzey LLC. 10/30/2014 October 30, 2014 1
Global Clinical Supplies & The Road Less Traveled: Navigating the bumps, pot holes and detours that come with the development and delivery of Investigational Products Lorna Briddick Managing Partner Brizzey
More informationSerious about safety. Seriously strategic about labeling. If you are serious about safety, you have to be seriously strategic about your labels.
Serious about safety. Seriously strategic about labeling. If you are serious about safety, you have to be seriously strategic about your labels. 02 Clintrak knows how: Strategically engineered. Quality
More informationIMP management at site. Dmitry Semenyuta
IMP management at site Dmitry Semenyuta TOP 5 FDA inspections finding 1999-2009 Center of Drug Evaluation and Research (CDER) Failure to follow the protocol Failure to keep adequate and accurate records
More informationMost recent research on clinical trials
Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE July/August 2012, Vol. 32 No. 4 www.pharmaceuticalengineering.org Copyright ISPE 2012 This article presents the R&D supply chain
More informationAdoption by GCP Inspectors Working Group for consultation 14 June 2011. End of consultation (deadline for comments) 15 February 2012
10 December 2013 EMA/INS/GCP/600788/2011 Compliance and Inspection Reflection paper on the use of interactive response technologies (interactive voice/web response systems) in clinical trials, with particular
More informationStrengthening Patient Engagement on Clinical Trials
Strengthening Patient Engagement on Clinical Trials Sandeep Raju DIA 21 st Annual EuroMeeting, Berlin March 25, 2009 Session summary Patient recruitment is expensive but inefficient Retention and Adherence
More informationNevirapine 200 mg tablets WHOPAR part 5 09/2010, version 1.0 (Matrix Laboratories Ltd), HA396 LABELLING. Page 1 of 8
LABELLING Page 1 of 8 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OR, WHERE THERE IS NO OUTER PACKAGING, ON THE IMMEDIATE PACKAGING HDPE bottle carton label 1. NAME OF THE MEDICINAL PRODUCT Nevirapine
More informationORACLE HEALTH SCIENCES INTERACTIVE RESPONSE TECHNOLOGY (IRT)
ORACLE HEALTH SCIENCES INTERACTIVE RESPONSE TECHNOLOGY (IRT) KEY BENEFITS FOR CLINICAL OPERATIONS Increase efficiency and safety in clinical supply chains with sophisticated algorithms and an easyto-use
More informationProduct Serialisation to Advance Pharmaceutical Authentication and Patient Safety
Product Serialisation to Advance Pharmaceutical Authentication and Patient Safety The Pharmaceutical Industry Takes On a New Global Challenge By: Gaurav Banerjee, Director, Technical Services - US & EU,
More informationEuropean Medicines Verification System (EMVS) European Pack Coding Guidelines
European Medicines Verification System (EMVS) European Pack Coding Guidelines June 2013 Revision History V1.0 June 2008 Initial Release V1.1 June 2008 Amended some typographical errors, added extra detail
More informationHow To Help The Global Healthcare User Group (Hug)
HUG Global Healthcare User Group - HUG GS1 s Brand Architecture 2 The global Healthcare User Group - HUG Mission: Lead the healthcare industry to the effective utilization and development of global standards
More informationEquipping your Forecasting Toolkit to Account for Ongoing Changes
Equipping your Forecasting Toolkit to Account for Ongoing Changes Presented by: Roger Parlett Supply Chain Manager January 23, 2014 Overview Forecast Set-up Objectives of Creating a Forecast Identify Critical
More informationStudy Participant Experiences
2013 Perceptions & Insights Study Report on Study Participant Experiences Regulatory agencies, ethical review committees, investigative sites, contract research organizations, and clinical research sponsors
More informationPosition Paper (II) Healthcare Provider Advisory Council Implementation in hospitals hindered by bar code symbol issues
I. Introduction Towards the end of 2011, GS1 Healthcare established the Healthcare Provider Advisory Council (HPAC) to be the forum for sharing and discussing the practical realities of implementation
More informationMedical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11
Effective Date: 09/12/06, 08/02/10, 3/2/11 Title: 1.0 OBJECTIVE: 1.1 This SOP describes the methods and policies for: Handling investigational drug Dispensing investigational drug 1.2. This procedure applies
More informationmsupply Pharmaceutical Supply Chain Software October 2013
msupply Pharmaceutical Supply Chain Software October 2013 Ease-of-use msupply has almost 15 years experience in providing solutions for medicines and vaccines supply chain, msupply is downloadable for
More informationAlgoritmos Procesos y Diseños S.A. +25 years developing tailored-made solutions for the Healthcare Community. Healthcare division
+25 years developing tailored-made solutions for the Healthcare Community Healthcare division Our Values Sucesful track-record improving clinical efficiency and financial performance One of the key suppliers
More informationGuidance on the content of a pharmacy manual to support clinical trial protocols
Guidance on the content of a pharmacy manual to support clinical trial protocols This guidance has been produced to help investigators with the content of pharmacy manuals for clinical trials. We gratefully
More informationClinical Supply Chain Management Driving Operational Performance
Clinical Supply Chain Management Driving Operational Performance July 2010 PwC Your presenters EER1 Ellen Reilly Managing Director Pharma & Life Sciences Advisory Services 400 Campus Drive Florham Park,
More informationHow to Utilize an IVRS for Efficient Management of Clinical Supplies
How to Utilize an IVRS for Efficient Management of Clinical Supplies Scott C. Wong IVRS Senior Systems Analyst Investigational Material Supply Chain Celgene Corporation Objective Provide a basic understanding
More informationClinical Trial Supply Chain Driving Transformation for Excellence
Clinical Trial Supply Chain Driving Transformation for Excellence October 20, 2009 2009 AMR Research, Inc. Page 1 Key Success Criteria of Life Sciences Companies Q84. What are your company s key success
More informationManaging the Extended Clinical Supply Chain in an Outsourced World
Managing the Extended Clinical Supply Chain in an Outsourced World Business Pressures on Sponsors, Contractors and CROs are Increasing Most recent research on clinical trials focuses on the outsourced
More informationCHAPTER 6 PROCUREMENT AND SUPPLY OF PHARMACEUTICAL PRODUCTS IN THE PUBLIC AND PRIVATE MEDICAL SECTORS
CHAPTER 6 PROCUREMENT AND SUPPLY OF PHARMACEUTICAL PRODUCTS IN THE PUBLIC AND PRIVATE MEDICAL SECTORS Overview 6.1 This chapter sets out the Review Committee s findings and recommendations on procurement
More informationClinical Development - Current Trends and Challenges
BIOTECH SUPPLY CHAIN ACADEMY October 8-9, 2012 Crowne Plaza, Foster City, CA Leveraging Technology to Transform the Clinical Trial Supply Chain Leon Wyszkowski : Fisher Clinical Supplies David Northrup
More informationDrug Pooling in Clinical Trial Supply Chain
Drug Pooling in Clinical Trial Supply Chain Drug pooling in clinical trial is a process where common IMPs or Non-IMPs are pooled together for similar protocols running at each site followed by pooled distribution
More informationPractical Applications for Clinical Demand and Operations Planning
Practical Applications for Clinical Demand and Operations Planning Randy Schwemmin Genentech Clinical Demand and Supply Planning Biotech Supply Chain Academy 8 November 2011 Agenda Vision for Clinical
More informationWelcome to OptumRx Your Prescription Benefit Program
Welcome to OptumRx Your Prescription Benefit Program OptumRx offers you more ways to improve your health, while keeping medications more affordable and accessible. Welcome to OptumRx OptumRx manages your
More informationTechnical guide 1. june 2011
Technical guide 1. june 2011 Bar code labelling on primary and secondary packages for pharmaceutical products patient safety Preface This technical guide is designed to help companies put bar code labels
More informationProfessional Standards and Guidance for the Sale and Supply of Medicines
Professional Standards and Guidance for the Sale and Supply of Medicines About this document The Code of Ethics sets out seven principles of ethical practice that you must follow as a pharmacist or pharmacy
More informationA PROVEN APPROACH to ACCELERATED CLINICAL DEVELOPMENT
Accelovance 2275 Research Boulevard, Suite 700 Rockville, MD 20850, United States Phone: +1.240.238.4900 Fax: +1.240.238.4901 Internet: www.accelovance.com email: gsmith@accelovance.com Contact Person:
More informationBusiness Process Management (BPM) Software
FlowCentric Processware 2013 FlowCentric Business Process Management (BPM) Software and Services enable organisations of all proportions, in a multitude of industries, to satisfy and often exceed their
More informationASCO. R&D Supply Chain and Clinical Trials Supply Management A Life Sciences Solution. Award for the "Best Business Transformation project 2010
ASCO Award for the "Best Business Transformation project 2010 R&D Supply Chain and Clinical Trials Supply Management A Life Sciences Solution Geert Crauwels Partner Life Sciences Industry Lodestone Amelia
More informationTransCelerate's Role in Transforming Pharmaceutical Trials Presentation to PCORNet
TransCelerate's Role in Transforming Pharmaceutical Trials Presentation to PCORNet Dalvir Gill, PhD - Chief Executive Officer 17 October, 2014 Presentation Objectives + TransCelerate History + Participating
More informationUse of barcodes to improve the medication process in the hospital
Use of barcodes to improve the medication process in the hospital Prof. Pascal BONNABRY Slovenian Pharmaceutical Society Ljubljana, October 26, 2009 To err is human USA Serious adverse events in 3% [2.9-3.7%]
More informationClinical Trial Logistics
Company Brochure Clinical Trial Logistics contents 1. 2. 3. 4. 5. 6. About us Values Facility Quality Management System Services Why PCS Clinical Trial Logistics about us MEET US PHARMA COMPLEX SOLUTIONS
More informationWHITE PAPER BUILDING THE NEXT GENERATION IRT: AN EXCLUSIVE LOOK UNDER THE HOOD OF IXRS 3
WHITE PAPER BUILDING THE NEXT GENERATION IRT: AN EXCLUSIVE LOOK UNDER THE HOOD OF IXRS 3 Interactive Response Technology (IRT) systems used to manage patient interactions and drug supplies during clinical
More informationApproximate cost of a single protocol amendment: $450,000
Insight brief 34% of protocol amendments are avoidable Approximate cost of a single protocol amendment: $450,000 Improving clinical development in emerging biopharma settings: How model based drug development
More informationA Stability Program for the Distribution of Drug Products
A Stability Program for the Distribution of Drug Products Teresa I. Lucas*, Rafik H. Bishara, and Robert H. Seevers Drug products must be transported in a manner that ensures products will be maintained
More information11 MEDICATION MANAGEMENT
1 11 MEDICATION MANAGEMENT OVERVIEW OF MEDICATION MANAGEMENT Depending on the size, structure and functions of the health facility, there may be a pharmacy with qualified pharmacists to dispense medication,
More informationEnd to end Clinical Trial Supply Management with SAP
End to end Clinical Trial Supply Management with SAP by Infosys Lodestone CTSM is a leading factor in conducting clinical studies. Table of Contents A Leading Factor in conducting Clinical Studies is the
More informationEducation: Bachelor s degree in Pharmacy or Doctorate in Pharmacy (PharmD)
Pharmacist Job Title: Pharmacist Education: Bachelor s degree in Pharmacy or Doctorate in Pharmacy (PharmD) Location: divvydose, Rock Island, IL Job Type: Full-time FLSA Status: not exempt Company Description
More informationThe registry of the future: Leveraging EHR and patient data to drive better outcomes
The registry of the future: Leveraging EHR and patient data to drive better outcomes Brian J. Kelly, M.D. President, Payer and Provider Solutions, Quintiles Jason Colquitt, VP, IT, Head of RWLPR IT, Global
More informationPrescription Drug Information for Patients: History
Prescription Drug Information for Patients: History 1500s: Ethical Statutes of Royal College of Physicians Let no physician teach the people about medicines or even tell them the names of the medicines,
More informationIntroduction 2. 1. The Role of Pharmacy Within a NHS Trust 3. 2. Pharmacy Staff 4. 3. Pharmacy Facilities 5. 4. Pharmacy and Resources 6
Index Index Section Page Introduction 2 1. The Role of Pharmacy Within a NHS Trust 3 2. Pharmacy Staff 4 3. Pharmacy Facilities 5 4. Pharmacy and Resources 6 5. Prescription Charges 7 6. Communication
More informationThe Business. for REDUCING DRUG ADMINISTRATION ERRORS USING 2D BARCODES
DnCirP+ A);. 1 39d~ - 71-\n- COMMERCIAL - IN - CONFIDENCE The Business Case for REDUCING DRUG ADMINISTRATION ERRORS Prepared by Mike Sim Chief Executive Officer Advias (Advanced Information Assurance Solutions
More informationLogistics. Drug Pooling in the Clinical Trial Supply Chain
Drug Pooling in the Clinical Trial Supply Chain Abstract Global clinical trials require efficient and robust supply chain which can bring more transparency and can introduce risk mitigation strategies.
More informationGRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors
GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors This course is a distance-learning program that will culminate in a Graduate
More informationReflection paper on the Use of Interactive Response Technologies (Interactive Voice/Web Response Systems) in Clinical Trials
1 2 3 5 August 2011 EMA/INS/GCP/600788/2011 Compliance and Inspection 4 5 6 7 Reflection paper on the Use of Interactive Response Technologies (Interactive Voice/Web Response Systems) in Clinical Trials
More informationI am not a prospect I am a partner
IntelliRx, Transforming Prospect to Partner I am not a prospect I am a partner Scalable Systems Life Science & Healthcare Practices Improve Your DNA Data, Numbers & Analytics Intelli Rx Scalable Systems
More informationBringing health within your reach. Chronic Medication Designated Service Provider (DSP) Ruby. Emerald. Onyx
Bringing health within your reach 2009 Chronic Medication Designated Service Provider (DSP) Ruby Emerald Onyx An Overview: The GEMS Chronic Medication DSP Medipost Pharmacy is the Designated Service Provider
More informationWhich Apps Does FDA Regulate?
Which Apps Does FDA Regulate? Bradley Merrill Thompson 2015 EPSTEIN BECKER & GREEN, P.C. ALL RIGHTS RESERVED.. 1 Topics for Discussion Which apps does FDA regulate? Enforcement Discretion Pharma Apps Future
More informationPharmacy Apprenticeships
Pharmacy Apprenticeships JOB TITLE: BAND: BASE: Pharmacy Technician Pharmacy Department Pharmacy Assistant Pharmacy Department Apprentice Leicester Royal Infirmary Leicester General Hospital Glenfield
More informationJoint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009
Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009 The innovative pharmaceutical industry 2 is committed to the transparency
More informationRFID: The Cure for the Clinical Trial Blues. Joe Pleshek, President & CEO
RFID: The Cure for the Clinical Trial Blues Joe Pleshek, President & CEO Contents Introduction... 1 Why RFID?... 1 Why Clinical Trials?... 2 The View from a CRO... 3 It s Not Just About Managing Data...
More informationHealthcare Logistics. Delivered by
Healthcare Logistics OUTSOURCING Survey 2013 A recent survey by Healthcare Packaging Magazine and UPS provides insight into how healthcare logistics is managed, what is driving change, and what challenges
More informationSingapore Electronic Medicines Management Experience
Singapore Electronic Medicines Management Experience Angelina Tan Senior Principal Pharmacist, Singapore General Hospital 17 th October 2014 WAMSG Symposium Singapore General Hospital (SGH) World s 2nd
More informationIDIS CLINICAL TRIAL PROCUREMENT STRATEGIES. A trusted source for all of your global comparator needs
IDIS CLINICAL TRIAL PROCUREMENT STRATEGIES A trusted source for all of your global comparator needs WHAT YOU NEED, WHEN YOU NEED IT We typically source over 90% of comparators directly from the manufacturers
More informationIXRS Interactive Voice and Web Response System. MTN Annual Meeting ASPIRE Trial
IXRS Interactive Voice and Web Response System MTN Annual Meeting ASPIRE Trial Presenter: Tracie DiPasquale Materials Planning and Supply Chain Lead MTN Regional Meeting: 3-October-2012 Overview Introduction
More informationLicensed Pharmacy Technician Scope of Practice
Licensed Scope of Practice Adapted from: Request for Regulation of s Approved by Council April 24, 2015 Definitions In this policy: Act means The Pharmacy and Pharmacy Disciplines Act means an unregulated
More informationBusiness Process Management & Workflow Solutions
Business Process Management & Workflow Solutions Connecting People to Process, Data & Activities TouchstoneBPM enables organisations of all proportions, in a multitude of disciplines, the capability to
More informationSelect Healthcare Themes and Investment Opportunities
Select Healthcare and Demographic Shift Towards Older Population There were around 40 million Americans that are 65 and older in 2010 2 The population of seniors 65 and older is set to grow to 55 million
More informationImplementation manual for barcoding using GS1 global standards for tracing and tracking of pharmaceuticals and drugs for exports
Implementation manual for barcoding using GS1 global standards for tracing and tracking of pharmaceuticals and drugs for exports To facilitate compliance with DGFT Public Notice No. 59(RE-2010)/2009-2014
More informationImproving Patient Safety and Supply Chain Efficiency with GS1 Standards in HEALTHCARE
Improving Patient Safety and Supply Chain Efficiency with GS1 Standards in HEALTHCARE 1 GS1 STANDARDS IN HEALTHCARE Together, we re making it possible to follow drugs and medical devices from the manufacturer
More informationExtemporaneously Prepared Early Phase Clinical Trial Materials
Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS, RAC Eli Lilly & Co. Regulatory Advisor International Consortium for Innovation & Quality in Pharmaceutical Development
More informationDeveloping a Strategy to Optimize Clinical Trial Supplies
Developing a Strategy to Optimize Clinical Trial Supplies Medidata and other marks used herein are trademarks of Medidata Solutions, Inc. All other trademarks are the property of their respective owners.
More informationHealthcare Delivery. Transforming. through Mobility Solutions. A Solution White Paper - version 1.0
Transforming Healthcare Delivery through Mobility Solutions A Solution White Paper - version 1.0 HTC Global Services HTC Towers, No. 41, GST Road, Guindy, Chennai - 600 032, India. Ph: +91 44 4345 3500
More informationA Guide to Clinical Trials
A Guide to Clinical Trials For young people with cancer and their parents Children s Cancer and Leukaemia Group www.cclg.org.uk Original booklet produced in conjunction with the CCLG Patient Advocacy Committee.
More information2015 UPS Healthcare Forum. Pushing What s Possible
2015 UPS Healthcare Forum Pushing What s Possible Reinventing Cold Chain For Controlled Room Temperature Products: Reconciling Compliance with Cost Effectiveness Tim Fosnough, Global Director of Freight
More informationStreamlining clinical trial supply management
Life Sciences Clinical Trial Supply Management Streamlining clinical trial supply management Driving faster, more effective clinical trials In this white paper A critical step of the development chain:
More informationInvestigational Drugs: Investigational Drugs and Biologics
: I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place
More informationRemove Access Barriers and Maximize Product Uptake with an Integrated Hub Model Approach
Remove Access Barriers and Maximize Product Uptake with an Integrated Hub Model Approach When it comes to supporting the clinical and marketing objectives of any pharmaceutical franchise, helping to remove
More informationPharmaceutical Distribution Security Alliance (PDSA)
Pharmaceutical Distribution Security Alliance (PDSA) Our Mission The Pharmaceutical Distribution Security Alliance's (PDSA) mission is to develop and help enact a federal policy proposal that enhances
More informationQuality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion
Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS Eli Lilly & Co. Principal Consultant - Regulatory PDA/FDA Joint September 20 th, 2011
More informationHealth Care Job Information Sheet #20. Clinical Research
Health Care Job Information Sheet #20 Clinical Research A. Background B. Occupations 1) Clinical Research Associate (Study Monitor) 2) Clinical Research Coordinator 3) Other positions in the field C. Labour
More informationGUIDELINES FOR DRUG DONATIONS. A WHO/ Government of Vanuatu guide for those accepting and making donations of drugs.
INTRODUCTION GUIDELINES FOR DRUG DONATIONS A WHO/ Government of Vanuatu guide for those accepting and making donations of drugs. Why do we need guidelines on the donation of drugs Donations of medicines
More informationUsing IVRS in Clinical Trial Management
Using IVRS in Clinical Trial Management Bill Byrom Interactive voice response systems can work for project managers as an inventory management tool, a real-time project information tool, and a subject
More informationMarket Access for Medical Technology & Pharmaceutical Companies An Organizational Priority in Times of Economic Austerity and Reform
Market Access for Medical Technology & Pharmaceutical Companies An Organizational Priority in Times of Economic Austerity and Reform By Joakim Steen Mikkelsen, Managing Healthcare Counselor, Embassy of
More informationThrifty White Pharmacy 9/5/2014. Specialty Pharmacy. Specialty Pharmacy: The Opportunities and the Challenges
Specialty Pharmacy: The Opportunities and the Challenges MPhA Annual Conference September 12, 2014 Justin Heiser, PharmD Senior Vice President, Pharmacy Operations Specialty Pharmacy High cost and/or high
More informationEngaging E-Patients in Clinical Trials through Social Media. Patient Recruitment and the E-Patient: A Survey Analysis
Engaging E-Patients in Clinical Trials through Social Media Patient Recruitment and the E-Patient: A Survey Analysis Introduction Social media is a powerful medium for reaching patients engaged in their
More informationInteractive Response Technologies
Interactive Response Technologies Increasing accuracy and efficiency in clinical trials To increase the accuracy and efficiency of conducting your global clinical trials, ICON s Interactive Response Technologies
More informationContents General Information... 1. General Information
Contents General Information... 1 Preferred Drug List... 2 Pharmacies... 3 Prescriptions... 4 Generic and Preferred Drugs... 5 Express Scripts Website and Mobile App... 5 Specialty Medicines... 5 Prior
More informationGS1 Healthcare Discussion paper on Mobile Applications and Services in Healthcare
Mobile Applications and Services In the last 20 years there has been a significant growth of mobile communication devices, such as mobile/cell phones, tablet computers and personal digital assistants (PDAs);
More informationPHARMACEUTICAL SOCIETY OF SINGAPORE (PSS) CERTIFIED PHARMACY TECHNICIAN COURSE WSQ ADVANCED CERTIFICATE IN HEALTHCARE SUPPORT (PHARMACY SUPPORT)
AC ANNEX 1 & 2 PHARMACEUTICAL SOCIETY OF SINGAPORE (PSS) CERTIFIED PHARMACY TECHNICIAN COURSE WSQ ADVANCED CERTIFICATE IN HEALTHCARE SUPPORT (PHARMACY SUPPORT) 29th CPTC intake 12/01/16 to 17/11/16 (updated
More informationTEMPLATE DATA MANAGEMENT PLAN
TEMPLATE DATA MANAGEMENT PLAN ICRIN (QM sub group) Version: XX Date: XXXXXXX Page 1 of 6 1.0 Document Ownership The Data Management Plan (DMP) will be initiated and subsequently owned by the Data Manager
More informationGlobal Drug Development: Keeping Australia Competitive
: Keeping Australia Competitive Mitch Kirkman, Manager Process, Training & Quality International Clinical Research Operations & Oncology General Monitoring Organisation 07/08 April 2011 Keeping Australia
More informationICH CRA Certification Guide March 2009
ICH CRA Certification Guide March 2009 ICH CRA CERTIFICATION GUIDE... 1 GENERAL INFORMATION... 2 BENEFITS OF CERTIFICATION... 2 INDUSTRY RECOGNITION... 2 ABOUT THE EXAM... 2 CRA DEFINITION... 2 REQUIREMENTS
More informationWonderware MES/Operations Managing the transformation of materials into finished products in real time
Wonderware MES/Operations Managing the transformation of materials into finished products in real time Wonderware offers a complete set of MES software functionality to digitize your industrial operations
More informationRoadmap for study startup
How-To Guide Roadmap for study startup Deploying Adobe technology to automate clinical study startup procedures Section 1: Introduction and overview 2 1.1 Introduction 2 1.2 Overview of the clinical study
More informationNG Healthcare Payers June 10 th 12 th, 2015 JW Marriott Miami, Florida Day One June 10 th. Day Two June 11 th
NG Healthcare Payers June 10 th 12 th, 2015 JW Marriott Miami, Florida Day One June 10 th 16:30 18:00 Roundtable 1: Split-Streams Track 1: Healthcare becoming a Digital Business Track 2: Transformation
More informationLeveraging Mobile Health Technology for Patient Recruitment: An Emerging Opportunity
Leveraging Mobile Health Technology for Patient Recruitment: An Emerging Opportunity In Introduction The adoption of mobile devices smartphones and electronic tablets is proceeding at an astounding pace.
More information